Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life

The German Lung Cancer Cooperative Group (GLCCG) is assessing the impact of chemoradiation in addition to chemotherapy in the neoadjuvant treatment of stage III NSCLC. After three cycles of cisplatin/etoposide patients receive either hyperfractionated radiotherapy (RT) with concurrent carboplatin/vi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2004-04, Vol.44 (1), p.89-97
Hauptverfasser:	Schumacher, Andrea, Riesenbeck, Dorothea, Braunheim, Michael, Wewers, Dieter, Heinecke, Achim, Semik, Michael, Hoffknecht, Petra, Macha, Hans N, Klinke, Folker, Schmidt, Ernst-Wilhelm, Willich, Normann, Berdel, Wolfgang E, Thomas, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carboplatin - administration & dosage Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - radiotherapy Chemoradiation Cisplatin - administration & dosage Combined Modality Therapy Combined modality treatment Dose Fractionation Dyspnea - etiology Etoposide - administration & dosage Female German lung cancer cooperative group Health Status Humans Locally advanced non-small cell lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Male Medical sciences Middle Aged Neoadjuvant treatment Pain Pneumology Quality of Life Tumors of the respiratory system and mediastinum Vindesine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!